Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000169404 | SCV000220803 | likely pathogenic | Pendred syndrome | 2014-10-15 | criteria provided, single submitter | literature only | |
Labcorp Genetics |
RCV001061760 | SCV001226515 | pathogenic | not provided | 2023-05-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Trp640*) in the SLC26A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A4 are known to be pathogenic (PMID: 16283880, 25394566, 26252218, 26445815). This variant is present in population databases (rs368119540, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with clinical features of Pendred syndrome (PMID: 22412181, 25394566). ClinVar contains an entry for this variant (Variation ID: 189017). |
Genome- |
RCV000169404 | SCV002026958 | pathogenic | Pendred syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003474912 | SCV004201892 | pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2024-02-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005031696 | SCV005673650 | likely pathogenic | Autosomal recessive nonsyndromic hearing loss 4; Pendred syndrome | 2024-02-16 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000169404 | SCV001459932 | pathogenic | Pendred syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |